CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Bacterial vaginosis - Management
Basis for recommendation
Treating all symptomatic pregnant women
Screening for BV in asymptomatic pregnant women
- The National Institute for Health and Clinical Excellence (NICE) does not recommend routine screening for BV because the evidence suggests that identification and treatment of asymptomatic BV does not lower the risk for pre-term birth and other adverse reproductive outcomes [NICE, 2008].
- The British HIV Association recommends screening for BV in pregnant women who are infected with HIV because there is an increased risk of mother-to-child transmission of HIV-1 in the presence of BV [de Ruiter et al, 2008].
Seeking advice regarding whether to treat an asymptomatic pregnant woman
- Because the evidence regarding the treatment of BV to prevent adverse outcomes in pregnancy is conflicting, CKS recommends that the management of asymptomatic pregnant women be considered on an individual basis, after discussion with the woman's obstetrician.
© NHS Institute for Innovation and Improvement